Suppr超能文献

系统性异维A酸治疗对痤疮患者黏液纤毛清除功能及鼻黏膜表面的影响。

Effect of systemic isotretinoin therapy on mucociliary clearance and nasal surface mucosa in acne patients.

作者信息

Takci Zennure, Simsek Gulcin Guler, Karabulut Hayriye, Buran Yunus, Karadag Ayse Serap

出版信息

J Drugs Dermatol. 2013 Aug;12(8):e124-8.

Abstract

BACKGROUND

Currently, there are no studies investigating the topical or systemic effects of retinoids on human nasal mucosa. We aimed to investigate the effect of systemic isotretinoin therapy on mucociliary transport and nasal surface mucosa using the saccharine test (ST) and nasal cytology techniques.

METHODS

A total of 30 patients with severe or moderate acne were enrolled in this study. The median prescribed dose of isotretinoin was 0.75 mg per kg per day. Clinical and biochemical examinations were carried out periodically. The ST and nasal cytology were performed before treatment and during the third month of therapy.

RESULTS

Of the 30 patients who initially agreed to participate in the research, 21 completed the study (18 female and 3 male, mean ± standard deviation (SD) aged 20.9 ± 4.7 years, range 15-32 years). There was a significant difference between the mucociliary clearance time for subjects in the pre- and post-treatment periods (173.8 ± 89.2 seconds vs 245.2 ± 191.6 seconds, respectively; P=.009). Cytological examination revealed that the squamous cell ratio was significantly lower and the reactive changes of the respiratory epithelium were significantly higher 3 months after isotretinoin therapy than before therapy (P=.010, P=.002, respectively). There were mild signs of inflammation according to the number of neutrophilic leukocytes (8.3% vs 26.6%, P=.06) after 3 months of isotretinoin therapy.

CONCLUSION

Systemic isotretinoin alters the mucociliary transport, decreases the squamous cell ratio, increases the reactive changes in the respiratory epithelium significantly, and increases neutrophils in the nasal surface mucosa in the third month of treatment

摘要

背景

目前,尚无关于维甲酸对人体鼻黏膜局部或全身作用的研究。我们旨在通过糖精试验(ST)和鼻细胞学技术,研究系统性异维甲酸治疗对黏液纤毛运输和鼻表面黏膜的影响。

方法

本研究共纳入30例中重度痤疮患者。异维甲酸的中位处方剂量为每日每千克0.75毫克。定期进行临床和生化检查。在治疗前和治疗第三个月进行ST和鼻细胞学检查。

结果

最初同意参与研究的30例患者中,21例完成了研究(18例女性,3例男性,平均±标准差(SD)年龄20.9±4.7岁,范围15 - 32岁)。治疗前后受试者的黏液纤毛清除时间存在显著差异(分别为173.8±89.2秒和245.2±191.6秒;P = 0.009)。细胞学检查显示,异维甲酸治疗3个月后,鳞状细胞比例显著降低,呼吸上皮的反应性变化显著高于治疗前(分别为P = 0.010,P = 0.002)。根据中性粒细胞数量,异维甲酸治疗3个月后有轻度炎症迹象(8.3%对26.6%,P = 0.06)。

结论

系统性异维甲酸改变黏液纤毛运输,降低鳞状细胞比例,显著增加呼吸上皮的反应性变化,并在治疗第三个月增加鼻表面黏膜中的中性粒细胞

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验